What Is The Current and Historic Market Size Analysis Of The Respiratory Oxygen Delivery Devices Market?
The respiratory oxygen delivery devices market has seen considerable growth due to a variety of factors.
• The respiratory oxygen delivery devices market has experienced substantial growth in recent years. It will grow from $15 billion in 2024 to $16.66 billion in 2025, at a compound annual growth rate (CAGR) of 11.0%.
The growth has been driven by the rising prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, the expanding aging population worldwide, growing awareness of respiratory health, increased healthcare expenditure in emerging economies, and a higher adoption of homecare respiratory therapy.
What Are The Predictions for The Respiratory Oxygen Delivery Devices Market in the Coming Years?
The respiratory oxygen delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• The respiratory oxygen delivery devices market is expected to reach $25.01 billion by 2029 at a CAGR of 10.7%.
This growth is attributed to the rising demand for personalized medicine in respiratory care, the expansion of home healthcare services and remote patient monitoring, increasing R&D investments, and a greater focus on preventive healthcare. Key trends include technological innovations, a shift towards value-based care models, the integration of telehealth and remote monitoring into respiratory therapy, the use of wearables and mobile applications for self-management, and the adoption of 3D printing in manufacturing.
Which Drivers Are Accelerating Growth In The Respiratory Oxygen Delivery Devices Market?
The escalating incidence of asthma is anticipated to foster the expansion of the respiratory oxygen delivery device market in the future. Asthma, a long-term lung disorder characterized by airway inflammation and narrowing, results in repetitive bouts of wheezing, coughing, a feeling of tightness in the chest, and breathlessness. There is a growing trend of asthma cases primarily as a result of air pollution, exposure to allergens, genetically inherited tendencies, alterations in lifestyle and dietary routines, and urbanization. These respiratory oxygen delivery equipment play a critical role in asthma management by offering additional oxygen therapy to sufferers during asthma attacks, ensuring appropriate oxygen supply, and easing symptoms. Consequently, this improves respiratory performance and boosts the life quality of those affected by asthma. For example, data released by the National Center for Health Statistics (NCHS), a health statistics organization based in the U.S., in May 2024 indicated that the prevalence of current asthma among adults aged 18 years and above in the United States swelled from 8.4% in 2021 to 8.7% in 2022. Furthermore, the rate of asthma episodes in the past year for adults in that same age demographic increased from 3.3% in 2021 to 3.7% in 2022. As a consequence, the rising prevalence of asthma is fueling growth in the respiratory oxygen delivery device market.
What Are The Core Segments Of The Global Respiratory Oxygen Delivery Devices Market?
The respiratory oxygen delivery devices market covered in this report is segmented –
1) By Product: Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, Continuous Positive Airway Pressure (CPAP) Masks, Other Products
2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia, Other Disease Applications
3) By End-Use: Hospitals, Outpatient Facilities, Home Care
Subsegments:
1) By Oxygen Masks: Simple Oxygen Masks, Partial Rebreather Masks
2) By Nasal Cannula: Standard Nasal Cannula, High-Flow Nasal Cannula
3) By Venturi Masks: Fixed Venturi Masks, Adjustable Venturi Masks
4) By Non-Rebreather Masks: Adult Non-Rebreather Masks, Pediatric Non-Rebreather Masks
5) By Bag Valve Masks: Adult Bag Valve Masks, Pediatric Bag Valve Masks
6) By Continuous Positive Airway Pressure (Cpap) Masks: Full-Face Cpap Masks, Nasal Cpap Masks
7) By Other Products: Oxygen Concentrators, Oxygen Cylinders
Pre-Book The Respiratory Oxygen Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Respiratory Oxygen Delivery Devices Market?
The integration of state-of-the-art sensor control systems and interconnected communication features into oxygen concentrator devices is becoming increasingly important for companies in the respiratory oxygen delivery device market. This focus aims at boosting patient monitoring, enhancing treatment results, and optimizing healthcare provision procedures. The use of pressure swing adsorption (PSA) technology in oxygen concentrators effectively distinguishes oxygen from nitrogen in the surrounding air, offering dependable and continuous oxygen supply essential for patients requiring respiratory assistance. For example, in July 2022, a leading medical instrument production company based in Japan, OMRON Healthcare Co. Ltd., introduced a portable medical molecular sieve oxygen concentrator. This device ensures a consistent supply of pure oxygen by separating nitrogen, oxygen, and other elements from the atmospheric air using PSA technology. This feature maximizes efficiency and quality while retaining the gadget's portability. The device, which serves those with chronic obstructive pulmonary disease (COPD) and respiratory issues, is both a practical solution for in-home care providers and highly active users. It emphasizes mobility and durability with useful elements like a 360-degree silent wear-resistant universal caster wheel and a resilient design capable of withstanding impact.
Who Are the Key Players In The Respiratory Oxygen Delivery Devices Market?
Major companies operating in the respiratory oxygen delivery devices market are:
• Medtronic plc
• Air Liquide S.A.
• Becton Dickinson and Company
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Medline Industries Inc.
• ResMed Inc.
• Drägerwerk AG And Co. KGaA
• Smiths Group
• Teleflex Incorporated
• Masimo Corporation
• Chart Industries Inc.
• Fisher And Paykel Healthcare Limited
• Invacare Corporation
• Vyaire Medical Inc.
• Inogen Inc.
• Drive DeVilbiss Healthcare Inc.
• Hamilton Medical AG
• GaleMed Corporation
• Weinmann Emergency Medical Technology GmbH + Co. KG
• Precision Medical Inc.
• Allied Healthcare Products Inc.
• Salter Labs Inc.
• Nidek Medical Products Inc.
What Are The Regional Insights Into The Respiratory Oxygen Delivery Devices Market?
Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2024. The regions covered in the respiratory oxygen delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
